(Q43778406)

26 November 2017

title

Fluticasone propionate aqueous nasal spray in pregnancy rhinitis (English)

1 reference

26 November 2017

main subject

fluticasone propionate

1 reference

Ellegård EK

1

1 reference

26 November 2017

Hellgren M

series ordinal

2

1 reference

26 November 2017

Karlsson NG

series ordinal

3

1 reference

26 November 2017

publication date

1 October 2001

1 reference

26 November 2017

published in

Clinical Otolaryngology

1 reference

26 November 2017

volume

26

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

394-400

1 reference

Measuring health-related quality of life in rhinitis

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2001.00491.X

Snoring, pregnancy-induced hypertension, and growth retardation of the fetus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2001.00491.X

Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2001.00491.X

A placebo‐controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non‐allergic perennial rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2001.00491.X

Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2001.00491.X

Assessing degree of nasal patency by measuring peak expiratory flow rate through the nose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2001.00491.X

Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2001.00491.X

24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2001.00491.X

Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2001.00491.X

Systemic effects of two nasally administered glucocorticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2001.00491.X

Four-Week Use of Oxymetazoline Nasal Spray (Nezeril(R)) Once Daily at Night Induces Rebound Swelling and Nasal Hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2273.2001.00491.X

10.1046/J.1365-2273.2001.00491.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference